Clinical trials
Acquired Immunodeficiency Syndrome trials in South Africa
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
166 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 4 |
| 2004 | 5 |
| 2005 | 6 |
| 2007 | 5 |
| 2008 | 6 |
| 2009 | 10 |
| 2010 | 4 |
| 2011 | 5 |
| 2012 | 3 |
| 2013 | 6 |
| 2014 | 6 |
| 2015 | 10 |
| 2016 | 11 |
| 2017 | 7 |
| 2018 | 6 |
| 2019 | 10 |
| 2020 | 6 |
| 2021 | 12 |
| 2022 | 14 |
| 2023 | 8 |
| 2024 | 7 |
| 2025 | 5 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 123 |
| Recruiting | 16 |
| Active, not recruiting | 12 |
| Unknown status | 8 |
| Terminated | 4 |
| Withdrawn | 2 |
| No longer available | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ViiV Healthcare | 14 |
| University of California, Los Angeles | 7 |
| University of Cape Town | 7 |
| Johns Hopkins University | 6 |
| Merck Sharp & Dohme LLC | 6 |
| Tibotec Pharmaceuticals, Ireland | 6 |
| Boston University | 5 |
| Massachusetts General Hospital | 5 |
| Gilead Sciences | 4 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acquired Immunodeficiency Syndrome | 166 |
| HIV Infections | 44 |
| Tuberculosis | 12 |
| Infections | 10 |
| Substance-Related Disorders | 7 |
| Sexually Transmitted Diseases | 6 |
| Uterine Cervical Neoplasms | 5 |
| Alcoholism | 3 |
| COVID-19 | 3 |
| Immune System Diseases | 3 |
Trials
Showing 1 to 25 of 166. Each trial links to its page on Pharma Observatory.
66 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.